Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency - Slideshow By Sonic Mustang · March 28, 2026 · 1 min read beamsa transcripts Source: seekingalpha.com